BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11324681)

  • 1. Argatroban.
    McKeage K; Plosker GL
    Drugs; 2001; 61(4):515-22; discussion 523-4. PubMed ID: 11324681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Argatroban: a direct thrombin inhibitor with reliable and predictable anticoagulant actions.
    Escolar G; Bozzo J; Maragall S
    Drugs Today (Barc); 2006 Apr; 42(4):223-36. PubMed ID: 16703119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.
    Kondo LM; Wittkowsky AK; Wiggins BS
    Ann Pharmacother; 2001 Apr; 35(4):440-51. PubMed ID: 11302409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
    Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG;
    Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Argatroban.
    Kathiresan S; Shiomura J; Jang IK
    J Thromb Thrombolysis; 2002 Feb; 13(1):41-7. PubMed ID: 11994559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Argatroban in the management of heparin-induced thrombocytopenia.
    Babuin L; Pengo V
    Vasc Health Risk Manag; 2010 Sep; 6():813-9. PubMed ID: 20859550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Argatroban: pharmacological properties and anaesthesiological aspects].
    Kleinschmidt S; Stephan B; Pindur G; Bauer C
    Anaesthesist; 2006 Apr; 55(4):443-50. PubMed ID: 16389543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.
    Lewis BE; Wallis DE; Berkowitz SD; Matthai WH; Fareed J; Walenga JM; Bartholomew J; Sham R; Lerner RG; Zeigler ZR; Rustagi PK; Jang IK; Rifkin SD; Moran J; Hursting MJ; Kelton JG;
    Circulation; 2001 Apr; 103(14):1838-43. PubMed ID: 11294800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment options for heparin-induced thrombocytopenia.
    Greinacher A
    Am J Health Syst Pharm; 2003 Oct; 60 Suppl 5():S12-8. PubMed ID: 14593978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of argatroban.
    Jeske WP; Fareed J; Hoppensteadt DA; Lewis B; Walenga JM
    Expert Rev Hematol; 2010 Oct; 3(5):527-39. PubMed ID: 21083469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experimental and clinical results with the thrombin inhibitor Argatroban].
    Breddin HK
    Hamostaseologie; 2002 Aug; 22(3):55-9. PubMed ID: 12215762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A synopsis of the clinical uses of argatroban.
    Moledina M; Chakir M; Gandhi PJ
    J Thromb Thrombolysis; 2001 Oct; 12(2):141-9. PubMed ID: 11729365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Argatroban: a review of its use in the management of heparin-induced thrombocytopenia.
    Dhillon S
    Am J Cardiovasc Drugs; 2009; 9(4):261-82. PubMed ID: 19655821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novastan (brand of argatroban): a small-molecule, direct thrombin inhibitor.
    Hursting MJ; Alford KL; Becker JC; Brooks RL; Joffrion JL; Knappenberger GD; Kogan PW; Kogan TP; McKinney AA; Schwarz RP
    Semin Thromb Hemost; 1997; 23(6):503-16. PubMed ID: 9469622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Argatroban, a direct thrombin inhibitor for heparin-induced thrombocytopaenia: present and future perspectives.
    Serebruany MV; Malinin AI; Serebruany VL
    Expert Opin Pharmacother; 2006 Jan; 7(1):81-9. PubMed ID: 16370925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Argatroban: a direct thrombin inhibitor for heparin-induced thrombocytopenia and other clinical applications.
    Chen JL
    Heart Dis; 2001; 3(3):189-98. PubMed ID: 11975790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative parenteral anticoagulation with argatroban, a direct thrombin inhibitor.
    LaMonte MP; Brown PM; Hursting MJ
    Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):31-41. PubMed ID: 15723573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argatroban approved for heparin-induced thrombocytopenia.
    Miller JL
    Am J Health Syst Pharm; 2000 Sep; 57(18):1650. PubMed ID: 11006790
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacokinetic evaluation of argatroban for the treatment of acute coronary syndrome.
    Cruz-González I; López-Jiménez R; Perez-Rivera A; Yan BP
    Expert Opin Drug Metab Toxicol; 2012 Nov; 8(11):1483-93. PubMed ID: 22970706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argatroban use in heparin-induced thrombocytopenia.
    Boggio LN; Oza VM
    Expert Opin Pharmacother; 2008 Aug; 9(11):1963-7. PubMed ID: 18627333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.